| Title | Claps | Level | Year | L/Y |
|---|---|---|---|---|
|
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
26 auth. R. Phillips, W. Shi, M. Deek, N. Radwan, S. Lim, E. Antonarakis, S. Rowe, A. Ross, M. Gorin, C. Deville, S. Greco, Hailun Wang, S. Denmeade, C. Paller, S. Dipasquale, ...
This randomized clinical trial assesses whether treatment with stereotactic ablative radiotherapy vs observation improves oncologic outcomes in men with recurrent hormone-sensitive oligometastatic prostate cancer.
This randomized clinical trial assesses whether treatment with stereotactic ablative radiotherapy vs observation improves oncologic outcomes in men with recurrent hormone-sensitive oligometastatic prostate cancer.
Published in
JAMA Oncology
|
115
|
9 | 2020 |
Social Media Posts